LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.

MSYS

Microsaic Systems Plc

0.0275
0.00 (0.0%)
Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic Systems Plc LSE:MSYS London Ordinary Share GB00B547ZY09 ORD 0.01P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 0.0275 7,064,698 07:46:38
Bid Price Offer Price High Price Low Price Open Price
0.025 0.03 0.0275 0.0275 0.0275
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic Components, Nec 0.91 -3.53 -0.10 - 1.67
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:00 O 698 0.025 GBX

Microsaic Systems (MSYS) Latest News

Microsaic Systems (MSYS) Discussions and Chat

Microsaic Systems Forums and Chat

Date Time Title Posts
23/5/202318:20Microsaic Systems - 20181,115
17/5/202313:56Microsaic Systems - A Phoenix Rising from the Ashes697
16/2/202113:37Microsaic Systems806
06/1/202119:18Microsaic - Another pump and dump disaster81
24/7/201812:24Microsaic - miniaturised chip-size scientific instruments11

Add a New Thread

Microsaic Systems (MSYS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:35:000.036980.17O
10:45:230.032,500,000637.50O
10:14:050.03500,000130.50O
07:30:330.034,000,0001,084.00O
07:30:180.0364,00017.34O

Microsaic Systems (MSYS) Top Chat Posts

Top Posts
Posted at 26/4/2023 10:37 by dr biotech
Its been a long time since I posted on here. This company was never going to succeed, the product just isn't strong enough. I felt that at the time and whilst was always an outside chance they could license it to a major player its never happened. I think the share price was about 2p when I posted so this joins the 99% club. I've had plenty of failures similar to that and its not nice.

Looking forward it could become a small service company - but they are going to need to slim down and I'd even say delist as the time/cost of a listing may become more trouble than its worth. Good luck to those that retain the faith.








Dr Biotech - 04 Sep 2018 - 10:32:02 - 669 of 1096 Microsaic Systems - 2018 - MSYS
I wouldn't touch these.

Their single quad MS is interesting tech, but not game changing. It doesn't offer the resolution of a benchtop - it can't match a triple Quad for flexibility (or the capability for MS/MS) and it doesn't have the mass range of a ToF which is often better for large biomolecules.

I've been to a lot of production facilities in the UK and they all have full LC/MS systems to hand. A new LCMS costs around £150k (you can pick up a decent used system for about 30-40k. They are moderately complex and need someone who knows what they are doing, but once set up they can run samples every few minutes (uplc). I don't know of any manufacturers with off site facilities (admittedly as I work with the labs I wouldn't go to a site without a lab).

I know the people at Omicron in the UK. They are a small distributor with a handful of employees. I see them regularly enough and will ask them if they have had any traction with their customers.

Looking at the results I wonder if they will ever sell enough to cover their expenses. I'm not sure they will ever turn in a profit.

I hope I am wrong - the UK has a strong history in MS and it would be nice to see them succeed, but I won't be putting my money on it.

Posted at 18/4/2023 13:27 by onehanded
yes more lies on the RNS and trying to gloss it up and trying to push share price up before GB and his wife dump all their shares expected to be around 250 - 300 million in total before he is forced to leave when the FCA start to investigate. How he is still acting CEO after his apparent fraud at DVRG is anyone's guess, but that's the market we live in as small investors. Anyone buying now is throwing money away and as for a trade, once GB and wife start to sell the share price will half again. Clear sell and move on.

RNS says ' Although the first quarter of trading in the current year has started slowly', yes very slowly almost nothing, Will run out of money soon once GB takes all the money in pay and share options - a real disgrace to shareholders.......

Posted at 18/4/2023 12:16 by bbmsionlypostafter mk2
TW has been banging on about the fraud at DVRG & MSYS for literally years. He has held & voiced a v. low opinion of Gerry Brandon for ages, openly & repeatedly calling him a liar, a fraudster & more.


Https://shareprophets.com/views/67929/microsaic-deepverge-the-curse-of-gerry-brandon-it-gets-far-worse-for-both-companies


Yesterday it became apparent that Gerry Brandon had committed fraud by reporting bogus numbers for Deepverge (DVRG) before its last bailout placing. Brandon still runs Microsaic (MSYS) and you would have thought that advisers Singers and Turner Pope would have said that he had to go. How can they act for a proven fraudster? Quelle surprise, a retainer is worth more to these scholars and gentlemen than doing the right thing. But today, comes a shocking statement from Microsaic...

Posted at 17/4/2023 09:14 by onehanded
yes acting CEO for over a year!!!. Will find out soon this has no money and no contracts and money owed by DVRG will not be payed as not delivered anything. Company here is over.... GB the con man has done all MSYS holders as well. Sell and move on.
Posted at 17/4/2023 07:32 by onehanded
GB shown to be in charge of major possible fraud on DVRG revenue accounts and so expect on here as well. Hope no one still holding as may get a chance to get some money out first thing before the rush. Lots of warrants holders now useless it looks like for holders here. Without the support from DVRG the revenue and cash held in MSYS will be all but gone in cash and hardly any revenue.
Posted at 03/11/2022 09:26 by onehanded
seems MSYS have NOT been paid by DVRG as the above many RNS have said. Leaves a million £ hole in MSYS accounts and so will need more money raised or go bust. Of course DVRG would like that as they would pick it up for nothing. Scam by GB THE BIG LIE acting CEO for over a year. Hate to see MSYS shareholders get nothing. As with DVRG it has been a complete scam. I do not hold any here but do with DVRG and know the scam that has gone on and is still ongoing.
Posted at 02/8/2022 08:12 by onehanded
yup it's coming. No RNS for over a month, no new CEO replacement and not even looking. Deepverge share price up from lows and climbing, would be a good time to get the takeover on the table. Expect it will be soon as can't afford this share price to rise to much, once other's get a sniff, this could rise very quickly. Though expect near cash deal with maybe small shares offering in DVRG shares. May pick up more if it dips. Expect to see a biggest sell to keep price down. Takeover paperwork in progress in my view. Won't be long before cat out of the bag! May force early disclosure if share price rises.
Posted at 17/12/2021 13:45 by onehanded
GB and TP and mates are going to have best xmas ever. Don't give them any more of your money until confirmed revenue contracts (unless of course DVRG placing at 30p money is given in contracts to MSYS which he is a director and wife a large share holder at 0.1p!!!). People fed up and quite rightly showing it, a bit like Boris.

Here is how many 0.1p shares there were and many more option shares. TP made mega money... plus 20% more of those below were available!!! DID they get taken up, no one knows!

look where the warrants went to and none exercised yet!!

interesting 1 year left to admit those shares.

the issuance of Broker Warrants, whereby transferable warrants are to be issued to JIM Nominees Limited (as nominee on behalf of Turner Pope) for up to 997,000,000 New Ordinary Shares, equivalent to 20 per cent. of the Placing Shares issued to non-director placees, exercisable at the Placing Price for two years from Admission, as part of the consideration payable to Turner Pope for its services as placing agent to the Transaction;

19/1/21 RNS

Microsaic, the high technology company which develops point-of-need mass spectrometers, designed to improve the efficiency of chemical and biological workflows , announces that it has through Turner Pope Investments (TPI) Ltd ("Turner Pope") conditionally raised GBP5 million, before expenses, by way of an oversubscribed placing ("Placing") of 5,000,000,000 new Ordinary Shares ("Placing Shares") at a price of 0.1 pence per New Ordinary Share ("Placing Price"). A Conditional Broker Option granted to Turner Pope of up to 500,000,000 New Ordinary Shares ("Broker Option Shares") at a price of 0.1 pence per New Ordinary Share is open until 5.00 p.m. on 22 January 2021.

It is intended that Gerard Brandon will join the Board as Non-executive Chairman and Dr Nigel Burton will join the Board as a Non-executive Director, in each case immediately upon completion of the proposed Placing, at which time the current Non-executive Chairman, Peter Grant and Non-executive Director, Eric Yeatman, will also step down from the Board. Eric Yeatman will be retained as a consultant to the Company.

The Transaction is, amongst other things, conditional upon each of the Resolutions being passed at the forthcoming General Meeting and includes:

-- a Placing with certain institutional and other investors, to raise GBP5.0 million before expenses through the issue of 5,000,000,000 New Ordinary Shares at the Placing Price of 0.1 pence per New Ordinary Share.

-- the Placing Price is at a discount of approximately 50 per cent. to the closing middle market price of 0.2 pence per Existing Ordinary Share on 15 January 2021, being the latest practicable date prior to the publication of this announcement;

-- a Broker Option whereby the Broker, Turner Pope may conditionally allocate up to 500,000,000 New Ordinary Shares (in addition to the Placing Shares) (the "Broker Option Shares") at the Placing Price in order to give the flexibility to meet any additional demand for New Ordinary Shares arising during the period from the announcement of the Transaction up to 5.00 p.m. on 22 January 2021;

-- the issuance of the Fees Shares, whereby (i) 35,000,000 New Ordinary Shares are to be issued at the Placing Price in respect of the first year of fees due to Turner Pope for the provision of its broking services to the Company and (ii) 85,000,000 New Ordinary Shares are to be issued at the Placing Price in settlement of the first year's fees of the Proposed Directors;

-- the issuance of Broker Warrants, whereby transferable warrants are to be issued to JIM Nominees Limited (as nominee on behalf of Turner Pope) for up to 997,000,000 New Ordinary Shares, equivalent to 20 per cent. of the Placing Shares issued to non-director placees, exercisable at the Placing Price for two years from Admission, as part of the consideration payable to Turner Pope for its services as placing agent to the Transaction;

-- proposed Board changes and proposed directors being appointed on the terms summarised in Section 9 below, and proposed Director Options and Warrants over 750,000,000 New Ordinary Shares on the terms and subject to the performance condition set out in Section 10 below; and

-- a Share Reorganisation, further details of which are set out in Section 5 below, to enable shares to be issued at the Placing Price, which is below the current nominal value of the Ordinary Shares.

The proceeds receivable by the Company from the Transaction on Admission amount to GBP5.0 million (before expenses) and approximately GBP4.6 million (net of expenses) (assuming that no Broker Option Shares are issued). If the Broker Option Shares are issued in full, the proceeds receivable by the Company from the Transaction amount to GBP5.5 million (before expenses) and approximately GBP5.0 million (net of expenses).

Posted at 13/12/2021 14:33 by onehanded
Here is how many 0.1p shares there were and many more option shares. TP made mega money... plus 20% more of those below were available!!! DID they get taken up, no one knows!

look where the warrants went to and none exercised yet!!

interesting 1 year left to admit those shares.

the issuance of Broker Warrants, whereby transferable warrants are to be issued to JIM Nominees Limited (as nominee on behalf of Turner Pope) for up to 997,000,000 New Ordinary Shares, equivalent to 20 per cent. of the Placing Shares issued to non-director placees, exercisable at the Placing Price for two years from Admission, as part of the consideration payable to Turner Pope for its services as placing agent to the Transaction;

19/1/21 RNS

Microsaic, the high technology company which develops point-of-need mass spectrometers, designed to improve the efficiency of chemical and biological workflows , announces that it has through Turner Pope Investments (TPI) Ltd ("Turner Pope") conditionally raised GBP5 million, before expenses, by way of an oversubscribed placing ("Placing") of 5,000,000,000 new Ordinary Shares ("Placing Shares") at a price of 0.1 pence per New Ordinary Share ("Placing Price"). A Conditional Broker Option granted to Turner Pope of up to 500,000,000 New Ordinary Shares ("Broker Option Shares") at a price of 0.1 pence per New Ordinary Share is open until 5.00 p.m. on 22 January 2021.

It is intended that Gerard Brandon will join the Board as Non-executive Chairman and Dr Nigel Burton will join the Board as a Non-executive Director, in each case immediately upon completion of the proposed Placing, at which time the current Non-executive Chairman, Peter Grant and Non-executive Director, Eric Yeatman, will also step down from the Board. Eric Yeatman will be retained as a consultant to the Company.

The Transaction is, amongst other things, conditional upon each of the Resolutions being passed at the forthcoming General Meeting and includes:

-- a Placing with certain institutional and other investors, to raise GBP5.0 million before expenses through the issue of 5,000,000,000 New Ordinary Shares at the Placing Price of 0.1 pence per New Ordinary Share.

-- the Placing Price is at a discount of approximately 50 per cent. to the closing middle market price of 0.2 pence per Existing Ordinary Share on 15 January 2021, being the latest practicable date prior to the publication of this announcement;

-- a Broker Option whereby the Broker, Turner Pope may conditionally allocate up to 500,000,000 New Ordinary Shares (in addition to the Placing Shares) (the "Broker Option Shares") at the Placing Price in order to give the flexibility to meet any additional demand for New Ordinary Shares arising during the period from the announcement of the Transaction up to 5.00 p.m. on 22 January 2021;

-- the issuance of the Fees Shares, whereby (i) 35,000,000 New Ordinary Shares are to be issued at the Placing Price in respect of the first year of fees due to Turner Pope for the provision of its broking services to the Company and (ii) 85,000,000 New Ordinary Shares are to be issued at the Placing Price in settlement of the first year's fees of the Proposed Directors;

-- the issuance of Broker Warrants, whereby transferable warrants are to be issued to JIM Nominees Limited (as nominee on behalf of Turner Pope) for up to 997,000,000 New Ordinary Shares, equivalent to 20 per cent. of the Placing Shares issued to non-director placees, exercisable at the Placing Price for two years from Admission, as part of the consideration payable to Turner Pope for its services as placing agent to the Transaction;

-- proposed Board changes and proposed directors being appointed on the terms summarised in Section 9 below, and proposed Director Options and Warrants over 750,000,000 New Ordinary Shares on the terms and subject to the performance condition set out in Section 10 below; and

-- a Share Reorganisation, further details of which are set out in Section 5 below, to enable shares to be issued at the Placing Price, which is below the current nominal value of the Ordinary Shares.

The proceeds receivable by the Company from the Transaction on Admission amount to GBP5.0 million (before expenses) and approximately GBP4.6 million (net of expenses) (assuming that no Broker Option Shares are issued). If the Broker Option Shares are issued in full, the proceeds receivable by the Company from the Transaction amount to GBP5.5 million (before expenses) and approximately GBP5.0 million (net of expenses).

Posted at 12/8/2021 05:29 by city analyst1
Private investors would be wise to note the following:

On July 08, 2021, on the IMC (Investor Meet Company) channel, Microsaic’s head honcho, Glenn Tracey, gave an unequivocally bullish response to a private investor’s question on the current share price.

Using speech recognition software, and from 14:03mins to 15:40mins, I captured the entire dialogue verbatim. Here goes…

PRIVATE INVESTOR
“You’ve had a trail of good news recently showing a lot of traction since January. Do you think this is adequately reflected in the share price?

GLENN TRACEY
“I’m not surprised that question has come up. I mean, look at the news flow we’ve put out there;

• We’re the first to market!
• We’re the first in the world with an amazing way of getting biologics to market faster!
• We’re about to get a medical licence in China and sell our product into hospitals, of which there are 33,000 in China alone!

“Our news flow is month after month of really positive news.”

“And yes, we’re absolutely seeing churn in the share price. But pretty much all of it is short term churn. I can say, there’s very little institutional churn.”

“I think what we have to do is focus on the fundamentals of the business, which we are doing. There’s going to be more news coming out.”

“I mean, this is a company that has had £30m invested in it! We’ve got a fantastic channel ahead of us. We’re bringing new products to market.”

“You know, if you asked a CEO of any business, if their company was undervalued they are likely going to say yeah, of course they are. But, 0.25 of a pence, for this technology, and for this opportunity, for me is extremely undervalued. And hopefully soon, that share price will pop because the real value of this company is going to be seen.”

Https://www.youtube.com/watch?v=m5B6QH5kR1Y


Indiana poet, James Whitcomb Riley, once opined that, "If it looks like a duck, swims like a duck, and quacks like a duck, then it probably is a duck."

In other words, MSYS is displaying all the signs of a winning technology stock on the verge of take-off.

So my take on the company is simple: Against the backdrop of astonishing technological breakthroughs and commercial traction, the company is sporting a staggering risk-reward ratio and is, as a result, materially mispriced at 0.25pence per share (or £12.8m market cap).

Thus, I fully concur with the CEO and expect the share price to pop sooner rather than later.

AIMHO

Microsaic Systems share price data is direct from the London Stock Exchange
Your Recent History
LSE
MSYS
Microsaic ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230602 21:40:39